Clinical Trials Browser

OTHER × RC48 antibody × Gynecologic × Clear all

NCT07285941 2025-12-16

Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment

Phase 2 Recruiting

Ovarian Neoplasms

NCT06063018 2023-10-02

RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer

Phase 2 Recruiting

Cervical Cancer Recurrent